解读FGFR2代码:胃癌治疗中的创新目标
Alireza Tojjari1, Sarbajeet Nagdas2, Ali Saeed3
1Department of Medicine, Division of Hematology & Oncology, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA 15261, USA.
Current oncology (Toronto, Ont.)
|August 28, 2024
概括
纤维细胞生长因子受体2 (FGFR2) 是胃癌 (GC) 治疗的有希望的标. 针对FGFR2的治疗方法正在临床试验中,比目前的先进GC治疗方法提供了潜在的改善.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 胃肠病学 胃肠病学
背景情况:
- 胃癌 (GC) 是全球癌症相关死亡的主要原因.
- 目前对晚期GC的治疗方法提供了有限的生存益处.
- 纤维细胞生长因子受体 (FGFRs),特别是FGFR2,与GC发育和进展有关.
研究的目的:
- 审查FGFR2在胃癌中的生物学作用.
- 总结针对GC的临床试验中的FGFR2向药物.
- 讨论实施FGFR2向治疗的挑战.
主要方法:
- 临床前和临床研究的文献综述.
- 分析FGFR2表达及其与GC预后的相关性.
- 对GC的FGFR2抑制剂和抗体正在进行的临床试验的概述.
主要成果:
- 在GC中,FGFR2过度表达,特别是在扩散型中,并且与糟糕的结果有关.
- 目前正在研究针对FGFR2的多种小分子抑制剂和单克隆抗体.
- 这些药物正在作为单一疗法和与标准护理结合进行评估.
结论:
- 在胃癌中,FGFR2是重要的治疗点.
- 针对FGFR2的向疗法有望改善患者的治疗结果.
- 克服临床应用中的挑战对于实现FGFR2向治疗的全部好处至关重要.
更多相关视频
06:21Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
644
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K